Synta Pharmaceuticals Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $42.6M

Synta Pharmaceuticals General Information

Description

Developer of small molecule drugs for severe medical conditions. The company offers clinical and preclinical-stage drug candidates with mechanisms of action and novel chemical structures.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 45 Hartwell Avenue
  • Lexington, MA 02421
  • United States
+1 (781)
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • 45 Hartwell Avenue
  • Lexington, MA 02421
  • United States
+1 (781)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synta Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Merger/Acquisition 22-Jul-2016 $42.6M Completed Profitable
14. Debt Repayment 01-Apr-2014 Completed Profitable
13. 2PO 18-Nov-2013 Completed Profitable
12. Debt - General 01-Mar-2013 Completed Profitable
11. 2PO 11-Jan-2012 Completed Profitable
10. Debt - General 01-Mar-2011 Completed Profitable
9. 2PO 08-Jan-2010 Completed Profitable
8. IPO 06-Feb-2007 Completed Profitable
7. Later Stage VC (Series A) 02-Jun-2006 $40M $232M Completed Clinical Trials - Phase 3
6. IPO 10-Jun-2005 $90M Cancelled Clinical Trials - Phase 2
To view Synta Pharmaceuticals’s complete valuation and funding history, request access »

Synta Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Synta Pharmaceuticals’s complete cap table history, request access »

Synta Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of small molecule drugs for severe medical conditions. The company offers clinical and preclinical-stage drug
Pharmaceuticals
Lexington, MA

Kilmeaden, Ireland
 

Vienna, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Synta Pharmaceuticals Competitors (39)

One of Synta Pharmaceuticals’s 39 competitors is Genzyme Ireland, a Corporation company based in Kilmeaden, Ireland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genzyme Ireland Corporation Kilmeaden, Ireland
Pfizer (Vienna) Corporation Vienna, Austria
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA
Pfizer Pakistan Corporation Karachi, Pakistan
Regeneron Pharmaceuticals Formerly VC-backed Tarrytown, NY
You’re viewing 5 of 39 competitors. Get the full list »

Synta Pharmaceuticals Patents

Synta Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022079569-A Combination therapy for the treatment of ovarian cancer Inactive 29-Feb-2016
AU-2017227534-A1 Combination therapy for treatment of ovarian cancer Inactive 29-Feb-2016
AU-2023200554-A1 Combination therapy for treatment of ovarian cancer Inactive 29-Feb-2016
CA-3014680-A1 Combination therapy for treatment of ovarian cancer Pending 29-Feb-2016
EP-3423048-A1 Combination therapy for treatment of ovarian cancer Inactive 29-Feb-2016 A61K31/4196
To view Synta Pharmaceuticals’s complete patent history, request access »

Synta Pharmaceuticals Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Caxton (Europe) Hedge Fund Minority
Gollust Management Venture Capital Minority
Lowenthal Capital Partners Hedge Fund Minority
Mountain Trail Investments Venture Capital Minority
Wyandanch Partners Growth/Expansion Minority
To view Synta Pharmaceuticals’s complete investors history, request access »

Synta Pharmaceuticals Acquisitions (1)

Synta Pharmaceuticals’s most recent deal was a Reverse Merger with Madrigal Pharmaceuticals. The deal was made on 22-Jul-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Madrigal Pharmaceuticals 22-Jul-2016 Reverse Merger Pharmaceuticals
To view Synta Pharmaceuticals’s complete acquisitions history, request access »

Synta Pharmaceuticals FAQs

  • When was Synta Pharmaceuticals founded?

    Synta Pharmaceuticals was founded in 2000.

  • Where is Synta Pharmaceuticals headquartered?

    Synta Pharmaceuticals is headquartered in Lexington, MA.

  • What industry is Synta Pharmaceuticals in?

    Synta Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Synta Pharmaceuticals a private or public company?

    Synta Pharmaceuticals is a Private company.

  • What is the current valuation of Synta Pharmaceuticals?

    The current valuation of Synta Pharmaceuticals is .

  • What is Synta Pharmaceuticals’s current revenue?

    The current revenue for Synta Pharmaceuticals is .

  • How much funding has Synta Pharmaceuticals raised over time?

    Synta Pharmaceuticals has raised $426M.

  • Who are Synta Pharmaceuticals’s investors?

    Caxton (Europe), Gollust Management, Lowenthal Capital Partners, Mountain Trail Investments, and Wyandanch Partners have invested in Synta Pharmaceuticals.

  • Who are Synta Pharmaceuticals’s competitors?

    Genzyme Ireland, Pfizer (Vienna), BioMarin Pharmaceutical, Pfizer Pakistan, and Regeneron Pharmaceuticals are some of the 39 competitors of Synta Pharmaceuticals.

  • When was Synta Pharmaceuticals acquired?

    Synta Pharmaceuticals was acquired on 22-Jul-2016.

  • Who acquired Synta Pharmaceuticals?

    Synta Pharmaceuticals was acquired by Madrigal Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process